Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Renovis Inc (RNVS) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Renovis Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1118361.
Total stock buying since 2005: $2,106,508.
Total stock sales since 2005: $31,725,797.
Total stock option exercises since 2005: $214,776.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 884,444 | $2,106,508 | 800,000 | $1,788,000 | 0 | $0 |
| 2006 | 0 | $0 | 963,101 | $17,839,380 | 170,264 | $214,776 |
| 2005 | 0 | $0 | 767,504 | $12,098,417 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-04 | 20,000 | $45,598 | 800,000 | $1,788,000 | 0 | $0 |
| 2008-03 | 113,446 | $259,844 | 0 | $0 | 0 | $0 |
| 2008-02 | 750,998 | $1,801,066 | 0 | $0 | 0 | $0 |
| 2006-12 | 0 | $0 | 40,000 | $123,200 | 0 | $0 |
| 2006-11 | 0 | $0 | 51,852 | $168,011 | 0 | $0 |
| 2006-10 | 0 | $0 | 51,649 | $247,512 | 0 | $0 |
| 2006-09 | 0 | $0 | 6,000 | $88,176 | 0 | $0 |
| 2006-08 | 0 | $0 | 6,000 | $73,710 | 0 | $0 |
| 2006-07 | 0 | $0 | 6,000 | $92,118 | 0 | $0 |
| 2006-06 | 0 | $0 | 6,000 | $97,638 | 0 | $0 |
| 2006-05 | 0 | $0 | 8,650 | $149,256 | 58,911 | $72,872 |
| 2006-04 | 0 | $0 | 24,150 | $493,675 | 79,353 | $84,834 |
| 2006-03 | 0 | $0 | 702,150 | $15,107,394 | 21,000 | $36,410 |
| 2006-02 | 0 | $0 | 33,500 | $706,875 | 10,000 | $11,250 |
| 2006-01 | 0 | $0 | 27,150 | $491,815 | 1,000 | $9,410 |
| 2005-12 | 0 | $0 | 7,650 | $121,301 | 0 | $0 |
| 2005-11 | 0 | $0 | 16,650 | $234,240 | 0 | $0 |
| 2005-10 | 0 | $0 | 8,650 | $116,252 | 0 | $0 |
| 2005-09 | 0 | $0 | 8,650 | $114,486 | 0 | $0 |
| 2005-08 | 0 | $0 | 9,650 | $143,231 | 0 | $0 |
| 2005-07 | 0 | $0 | 20,650 | $312,057 | 0 | $0 |
| 2005-06 | 0 | $0 | 17,050 | $234,307 | 0 | $0 |
| 2005-05 | 0 | $0 | 678,554 | $10,822,543 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-04-22 | Mm Asset Management Inc. (10% Owner) | Buy | 10,000 | 2.28 | 22,799 |
| 2008-04-22 | Mm Asset Management Inc. (10% Owner) | Sale | 400,000 | 2.23 | 894,000 |
| 2008-04-22 | Mmcap International Inc. Spc (10% Owner) | Buy | 10,000 | 2.28 | 22,799 |
| 2008-04-22 | Mmcap International Inc. Spc (10% Owner) | Sale | 400,000 | 2.23 | 894,000 |
| 2008-03-07 | Mm Asset Management Inc. (10% Owner) | Buy | 28,400 | 2.27 | 64,610 |
| 2008-03-07 | Mmcap International Inc. Spc (10% Owner) | Buy | 28,400 | 2.27 | 64,610 |
| 2008-03-03 | Mm Asset Management Inc. (10% Owner) | Buy | 28,323 | 2.31 | 65,312 |
| 2008-03-03 | Mmcap International Inc. Spc (10% Owner) | Buy | 28,323 | 2.31 | 65,312 |
| 2008-02-21 | Mm Asset Management Inc. (10% Owner) | Buy | 14,834 | 2.44 | 36,194 |
| 2008-02-21 | Mmcap International Inc. Spc (10% Owner) | Buy | 14,834 | 2.44 | 36,194 |
| 2008-02-20 | Mm Asset Management Inc. (10% Owner) | Buy | 79,701 | 2.46 | 196,462 |
| 2008-02-20 | Mmcap International Inc. Spc (10% Owner) | Buy | 79,701 | 2.46 | 196,462 |
| 2008-02-13 | Mm Asset Management Inc. (10% Owner) | Buy | 12,402 | 2.56 | 31,687 |
| 2008-02-13 | Mmcap International Inc. Spc (10% Owner) | Buy | 12,402 | 2.56 | 31,687 |
| 2008-02-12 | Mm Asset Management Inc. (10% Owner) | Buy | 165,000 | 2.39 | 393,855 |
| 2008-02-12 | Mmcap International Inc. Spc (10% Owner) | Buy | 165,000 | 2.39 | 393,855 |
| 2008-02-11 | Mm Asset Management Inc. (10% Owner) | Buy | 103,562 | 2.34 | 242,335 |
| 2008-02-11 | Mmcap International Inc. Spc (10% Owner) | Buy | 103,562 | 2.34 | 242,335 |
| 2006-12-15 | Walker John Peter (Director) | Sale | 40,000 | 3.08 | 123,200 |
| 2006-11-20 | Goodman Corey S (President and CEO) | Sale | 1,852 | 3.38 | 6,261 |
| 2006-11-02 | Doyle John C (SVP, Finance/Operations & CFO) | Sale | 50,000 | 3.23 | 161,750 |
| 2006-10-27 | Goodman Corey S (President and CEO) | Sale | 20,649 | 3.52 | 72,663 |
| 2006-10-26 | Goodman Corey S (President and CEO) | Sale | 25,000 | 3.74 | 93,525 |
| 2006-10-02 | Goodman Corey S (President and CEO) | Sale | 6,000 | 13.55 | 81,324 |
| 2006-09-01 | Goodman Corey S (President and CEO) | Sale | 6,000 | 14.70 | 88,176 |
| 2006-08-01 | Goodman Corey S (President and CEO) | Sale | 6,000 | 12.29 | 73,710 |
| 2006-07-03 | Goodman Corey S (President and CEO) | Sale | 6,000 | 15.35 | 92,118 |
| 2006-06-01 | Goodman Corey S (President and CEO) | Sale | 6,000 | 16.27 | 97,638 |
| 2006-05-25 | Doyle John C (VP, Finance & CFO) | Option Ex | 10,300 | 1.24 | 12,741 |
| 2006-05-16 | Kelly Michael Gerald (SVP, Research & Development) | Sale | 1,000 | 15.70 | 15,700 |
| 2006-05-03 | Pathak Dushyant (VP, Corporate Development) | Option Ex | 48,611 | 1.24 | 60,131 |
| 2006-05-02 | Serafini Tito (VP, Technology) | Sale | 1,650 | 17.06 | 28,148 |
| 2006-05-01 | Goodman Corey S (President and CEO) | Sale | 6,000 | 17.57 | 105,408 |
| 2006-04-17 | Kelly Michael Gerald (SVP, Research & Development) | Sale | 1,000 | 18.65 | 18,650 |
| 2006-04-12 | Doyle John C (VP, Finance & CFO) | Option Ex | 30,000 | 1.24 | 37,110 |
| 2006-04-12 | Goodman Corey S (President and CEO) | Option Ex | 49,353 | .97 | 47,724 |
| 2006-04-06 | Goodman Corey S (President and CEO) | Sale | 12,500 | 20.29 | 253,625 |
| 2006-04-03 | Goodman Corey S (President and CEO) | Sale | 9,000 | 20.80 | 187,245 |
| 2006-04-03 | Serafini Tito (VP, Technology) | Sale | 1,650 | 20.70 | 34,155 |
| 2006-03-20 | Pathak Dushyant (VP, Corporate Development) | Sale | 2,000 | 24.00 | 48,000 |
| 2006-03-16 | Kelly Michael Gerald (SVP, Research & Development) | Sale | 4,000 | 23.38 | 93,520 |
| 2006-03-16 | Doyle John C (VP, Finance & CFO) | Sale | 20,000 | 23.37 | 467,440 |
| 2006-03-16 | Doyle John C (VP, Finance & CFO) | Option Ex | 20,000 | 1.35 | 27,000 |
| 2006-03-15 | Perry Marlene F (Vice President, Human Resource) | Sale | 1,000 | 22.72 | 22,720 |
| 2006-03-15 | Perry Marlene F (Vice President, Human Resource) | Option Ex | 1,000 | 9.41 | 9,410 |
| 2006-03-06 | Goodman Corey S (President and CEO) | Sale | 25,000 | 21.95 | 548,624 |
| 2006-03-02 | Serafini Tito (VP, Technology) | Sale | 3,650 | 22.00 | 80,300 |
| 2006-03-02 | Penhoet Edward (Director) | Sale | 625,000 | 21.40 | 13,375,000 |
| 2006-03-01 | Goodman Corey S (President and CEO) | Sale | 9,000 | 21.94 | 197,478 |
| 2006-02-27 | Walker John Peter (Director) | Sale | 20,000 | 21.72 | 434,340 |
| 2006-02-16 | Kelly Michael Gerald (SVP, Research & Development) | Sale | 1,000 | 20.36 | 20,360 |
| 2006-02-08 | Doyle John C (VP, Finance & CFO) | Option Ex | 10,000 | 1.12 | 11,250 |
| 2006-02-06 | Goodman Corey S (President and CEO) | Sale | 12,500 | 20.17 | 252,175 |
| 2006-01-26 | Perry Marlene F (Vice President, Huma) | Sale | 1,000 | 20.00 | 20,000 |
| 2006-01-26 | Perry Marlene F (Vice President, Huma) | Option Ex | 1,000 | 9.41 | 9,410 |
| 2006-01-26 | Goodman Corey S (President and CEO) | Sale | 2,439 | 20.00 | 48,780 |
| 2006-01-25 | Goodman Corey S (President and CEO) | Sale | 561 | 20.00 | 11,220 |
| 2006-01-25 | Serafini Tito (VP, Chief Discovery) | Sale | 2,000 | 20.00 | 40,000 |
| 2006-01-18 | Goodman Corey S (President and CEO) | Sale | 12,500 | 19.00 | 237,500 |
| 2006-01-17 | Kelly Michael Gerald (VP, Drug Discovery) | Sale | 1,000 | 18.18 | 18,180 |
| 2006-01-03 | Goodman Corey S (President and CEO) | Sale | 6,000 | 15.19 | 91,110 |
| 2006-01-03 | Serafini Tito (VP, Chief Discovery) | Sale | 1,650 | 15.17 | 25,025 |
| 2005-12-02 | Serafini Tito (VP, Chief Discovery) | Sale | 1,650 | 15.88 | 26,195 |
| 2005-12-01 | Goodman Corey S (President and CEO) | Sale | 6,000 | 15.85 | 95,106 |
| 2005-11-17 | Kelly Michael Gerald (VP, Drug Discovery) | Sale | 6,000 | 13.96 | 83,790 |
| 2005-11-15 | Kelly Michael Gerald (VP, Drug Discovery) | Sale | 3,000 | 15.00 | 45,000 |
| 2005-11-02 | Serafini Tito (VP, Chief Discovery) | Sale | 1,650 | 13.64 | 22,506 |
| 2005-11-01 | Goodman Corey S (President and CEO) | Sale | 6,000 | 13.82 | 82,944 |
| 2005-10-21 | Pathak Dushyant (VP, Corporate Develo) | Sale | 1,000 | 12.92 | 12,920 |
| 2005-10-03 | Goodman Corey S (President and CEO) | Sale | 6,000 | 13.51 | 81,048 |
| 2005-10-03 | Serafini Tito (VP, Chief Discovery) | Sale | 1,650 | 13.51 | 22,284 |
| 2005-09-21 | Pathak Dushyant (VP, Corporate Develo) | Sale | 1,000 | 13.10 | 13,100 |
| 2005-09-02 | Serafini Tito (VP, Chief Discovery) | Sale | 1,650 | 13.26 | 21,880 |
| 2005-09-01 | Goodman Corey S (President and CEO) | Sale | 6,000 | 13.25 | 79,506 |
| 2005-08-22 | Pathak Dushyant (VP, Corporate Develo) | Sale | 1,000 | 13.43 | 13,430 |
| 2005-08-10 | Moreadith Randall (Chief Medical Office) | Sale | 1,000 | 13.30 | 13,300 |
| 2005-08-02 | Serafini Tito (VP, Chief Discovery) | Sale | 1,650 | 15.24 | 25,139 |
| 2005-08-01 | Goodman Corey S (President and CEO) | Sale | 6,000 | 15.23 | 91,362 |
| 2005-07-21 | Pathak Dushyant (VP, Corporate Develo) | Sale | 1,000 | 16.20 | 16,200 |
| 2005-07-05 | Serafini Tito (VP, Chief Discovery) | Sale | 1,650 | 15.06 | 24,849 |
| 2005-07-01 | Goodman Corey S (President and CEO) | Sale | 12,000 | 15.06 | 180,672 |
| 2005-06-24 | Kelly Michael Gerald (VP, Drug Discovery) | Sale | 3,000 | 15.00 | 45,000 |
| 2005-06-21 | Pathak Dushyant (VP, Corporate Develo) | Sale | 1,000 | 14.69 | 14,690 |
| 2005-06-15 | Moreadith Randall (Chief Medical Office) | Sale | 5,400 | 13.35 | 72,063 |
| 2005-06-02 | Serafini Tito (VP, Chief Discovery) | Sale | 1,650 | 12.96 | 21,392 |
| 2005-06-01 | Goodman Corey S (President and CEO) | Sale | 6,000 | 13.53 | 81,162 |
| 2005-05-23 | Pathak Dushyant (VP, Corporate Develo) | Sale | 1,000 | 17.25 | 17,250 |
| 2005-05-12 | Walker John Peter (Director) | Sale | 10,000 | 18.00 | 180,000 |
| 2005-05-10 | Crowell Nancy M (Director) | Sale | 249,000 | 16.96 | 4,099,386 |
| 2005-05-09 | Crowell Nancy M (Director) | Sale | 150,000 | 15.65 | 2,347,949 |
| 2005-05-06 | Scolnick Edward M (Director) | Sale | 80,000 | 14.49 | 1,159,600 |
Insider trading activities including stock purchases, stock sales, and option exercises of RNVS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Renovis Inc (symbol RNVS, CIK number 1118361) see the Securities and Exchange Commission (SEC) website.